NO20060558L - Cyklopropylgruppe substituerte oksazolidinon antibiotiske midler og derivater derav - Google Patents

Cyklopropylgruppe substituerte oksazolidinon antibiotiske midler og derivater derav

Info

Publication number
NO20060558L
NO20060558L NO20060558A NO20060558A NO20060558L NO 20060558 L NO20060558 L NO 20060558L NO 20060558 A NO20060558 A NO 20060558A NO 20060558 A NO20060558 A NO 20060558A NO 20060558 L NO20060558 L NO 20060558L
Authority
NO
Norway
Prior art keywords
derivatives
group substituted
cyclopropyl group
antibiotic agents
substituted oxazolidinone
Prior art date
Application number
NO20060558A
Other languages
English (en)
Norwegian (no)
Inventor
Yasumichi Fukuda
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20060558L publication Critical patent/NO20060558L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
NO20060558A 2003-07-02 2006-02-02 Cyklopropylgruppe substituerte oksazolidinon antibiotiske midler og derivater derav NO20060558L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48390403P 2003-07-02 2003-07-02
US54698404P 2004-02-24 2004-02-24
PCT/US2004/020734 WO2005005398A2 (fr) 2003-07-02 2004-06-29 Antibiotiques a base d'oxazolidinone substituee par un groupe cyclipropyl et derives

Publications (1)

Publication Number Publication Date
NO20060558L true NO20060558L (no) 2006-02-02

Family

ID=34068173

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060558A NO20060558L (no) 2003-07-02 2006-02-02 Cyklopropylgruppe substituerte oksazolidinon antibiotiske midler og derivater derav

Country Status (23)

Country Link
US (2) US7462633B2 (fr)
EP (1) EP1646629B1 (fr)
JP (1) JP4607107B2 (fr)
KR (1) KR20060113625A (fr)
AR (1) AR044990A1 (fr)
AT (1) ATE471937T1 (fr)
AU (1) AU2004256083B2 (fr)
BR (1) BRPI0411688A (fr)
CA (1) CA2530140C (fr)
CL (1) CL2004001678A1 (fr)
DE (1) DE602004027811D1 (fr)
EC (1) ECSP056257A (fr)
IL (1) IL172785A0 (fr)
IS (1) IS8178A (fr)
MA (1) MA27938A1 (fr)
MX (1) MXPA06000228A (fr)
MY (1) MY140137A (fr)
NO (1) NO20060558L (fr)
NZ (1) NZ544237A (fr)
PE (1) PE20050732A1 (fr)
RU (1) RU2348628C2 (fr)
TW (1) TW200510421A (fr)
WO (1) WO2005005398A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2443410A1 (fr) * 2001-04-17 2003-04-03 Yasumichi Fukuda Antibiotiques oxazolidinone contenant du bicyclo[3.1.0] hexane et derives de ces derniers
US8324398B2 (en) * 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP2492264A3 (fr) 2003-06-03 2012-12-19 Rib-X Pharmaceuticals, Inc. Composes Heterocycliques Biaryle Et Procedes De Production Et d'utilisation Associes
CA2530140C (fr) 2003-07-02 2010-11-09 Merck & Co., Inc. Antibiotiques a base d'oxazolidinone substituee par un groupe cyclipropyl et derives
EP1646630A1 (fr) * 2003-07-02 2006-04-19 Merck & Co., Inc. Antibiotiques de type oxazolidinones et derives de ceux-ci
EP1713785A1 (fr) * 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Composes heterocycliques de biaryle halogenes et methodes de fabrication et d'utilisation
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US20100286211A1 (en) * 2004-10-08 2010-11-11 Biswajit Das Oxazolidinone derivatives as antimicrobials
WO2006133397A2 (fr) * 2005-06-08 2006-12-14 Rib-X Pharmaceuticals, Inc. Procede permettant de realiser la synthese de triazoles
US20090018123A1 (en) * 2005-06-20 2009-01-15 Milind D Sindkhedkar Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
AR054608A1 (es) * 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
WO2008150364A1 (fr) * 2007-05-23 2008-12-11 Merck & Co., Inc. Antagonistes du récepteur de la cyclopropylpyrrolidine orexine
CN106220621B (zh) * 2008-10-10 2019-06-11 默沙东公司 制备噁唑烷酮类的方法及含有噁唑烷酮类的组合物
NZ594408A (en) 2009-02-03 2014-03-28 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos
BR112013007566A2 (pt) 2010-09-28 2016-08-02 Panacea Biotec Ltd novos compostos bicíclicos
WO2017066964A1 (fr) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Composés oxazolidinone et procédés d'utilisation de ces derniers en tant qu'agents antibactériens

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053593A (en) 1975-11-26 1977-10-11 Lew Frumoff Medical product combining antimicrobial, antiporasitic and vitamin complex
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0610265B1 (fr) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Aryl- et heteroarylphenyloxazolidinones substituees, utilisees comme agents antibacteriens
DE69316240T2 (de) * 1992-12-08 1998-05-20 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
TW286317B (fr) 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
HRP960159A2 (en) 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
PT828741E (pt) 1995-05-11 2002-02-28 Upjohn Co Oxazolidinonas de diazinilo espirociclico e biciclico e de carbazinilo
MY116093A (en) 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO2000070758A1 (fr) 1999-05-14 2000-11-23 Kabushiki Kaisha Toshiba Dispositif d'onde acoustique de surface
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
EP1263742B1 (fr) 2000-02-10 2005-08-24 Pharmacia & Upjohn Company LLC Thioamides d'oxazolidinone a substituants amides de piperazine
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
BR0111280A (pt) * 2000-06-05 2003-06-10 Dong A Pharm Co Ltd Novos derivados de oxazolidinona e um processo para a preparação dos mesmos
PL363960A1 (en) * 2000-07-17 2004-11-29 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
WO2002027029A2 (fr) * 2000-09-27 2002-04-04 Lynx Therapeutics, Inc. Procede de mesure de l'abondance relative de sequences d'acides nucleiques
CA2424402A1 (fr) 2000-12-21 2002-08-01 Pharmacia & Upjohn Company Derives antimicrobiens de la quinolone et leur utilisation pour le traitement d'infections bacteriennes
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
CA2443410A1 (fr) 2001-04-17 2003-04-03 Yasumichi Fukuda Antibiotiques oxazolidinone contenant du bicyclo[3.1.0] hexane et derives de ces derniers
EP1448536A1 (fr) 2001-11-29 2004-08-25 Merck & Co., Inc. Antibiotiques de type oxazolidinone contenant de l'hexane cyclopropyle et derives de ceux-ci
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
TW200302095A (en) 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
IL163688A0 (en) 2002-02-28 2005-12-18 Astrazeneca Ab 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents
PL373802A1 (en) 2002-05-15 2005-09-19 Ranbaxy Laboratories Limited Polymorphic forms of phenyl oxazolidinone derivatives
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
EP1581524A2 (fr) * 2002-11-28 2005-10-05 AstraZeneca AB Derives d`oxazolidinones comme agents bactericides
TW200500360A (en) 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
BRPI0409217A (pt) * 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
EP1625124A1 (fr) 2003-05-06 2006-02-15 Ranbaxy Laboratories, Ltd. Derives d'oxazolidinone utiles comme agents antimicrobiens
EP1646630A1 (fr) 2003-07-02 2006-04-19 Merck & Co., Inc. Antibiotiques de type oxazolidinones et derives de ceux-ci
CA2529292A1 (fr) * 2003-07-02 2005-01-20 Merck & Co., Inc. Antibiotiques a base d'oxazolidinone et derives
CA2530140C (fr) * 2003-07-02 2010-11-09 Merck & Co., Inc. Antibiotiques a base d'oxazolidinone substituee par un groupe cyclipropyl et derives
EP1654259A1 (fr) 2003-07-02 2006-05-10 Merck & Co., Inc. Antibiotiques de type oxazolidinones a groupe cyclopropyle substitue et derives de ceux-ci

Also Published As

Publication number Publication date
EP1646629A2 (fr) 2006-04-19
IS8178A (is) 2005-12-13
PE20050732A1 (es) 2005-11-02
US7582659B2 (en) 2009-09-01
AR044990A1 (es) 2005-10-12
US7462633B2 (en) 2008-12-09
KR20060113625A (ko) 2006-11-02
DE602004027811D1 (de) 2010-08-05
RU2005140379A (ru) 2007-08-10
CL2004001678A1 (es) 2005-05-20
ECSP056257A (es) 2006-04-19
JP4607107B2 (ja) 2011-01-05
MY140137A (en) 2009-11-30
CA2530140A1 (fr) 2005-01-20
WO2005005398A2 (fr) 2005-01-20
EP1646629B1 (fr) 2010-06-23
RU2348628C2 (ru) 2009-03-10
US20050038092A1 (en) 2005-02-17
CA2530140C (fr) 2010-11-09
TW200510421A (en) 2005-03-16
MA27938A1 (fr) 2006-06-01
AU2004256083A1 (en) 2005-01-20
ATE471937T1 (de) 2010-07-15
MXPA06000228A (es) 2006-06-27
JP2007521281A (ja) 2007-08-02
AU2004256083B2 (en) 2007-10-11
NZ544237A (en) 2008-09-26
US20070203187A1 (en) 2007-08-30
BRPI0411688A (pt) 2006-12-26
WO2005005398A3 (fr) 2005-04-28
IL172785A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
NO20060558L (no) Cyklopropylgruppe substituerte oksazolidinon antibiotiske midler og derivater derav
LTC1699784I2 (lt) Nauji oksazolidinono dariniai
NO20065613L (no) 3-karbamoyl-2-pyridonderivat.
RS53503B1 (en) AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR
RS52519B (en) SPIROCYCLIC COMPOUNDS WHICH ARE INHIBITORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1
NO20091858L (no) Hydrobenzamid derivater som inhibitorer av HSP90
HK1145324A1 (en) Method for preparing disubstituted piperidine and intermediates
RS53152B (en) NEW ANTIBACTERIAL AGENTS FOR TREATMENT OF Gram POSITIVE INFECTIONS
NO20080080L (no) Organiske forbindelser
WO2009106817A3 (fr) Composé
EA200500283A1 (ru) Производные оксазолидинона как противомикробные средства
WO2010058423A3 (fr) Nouveaux agents antimicrobiens
GEP20125660B (en) Improved organic compounds
PE20080283A1 (es) Profarmacos antimicrobianos de oxazolidinona
BR0308643A (pt) Composto do derivado do ácido piridobenzoxazina carboxìlico e agente antibacteriano contendo o mesmo
NO20070870L (no) Oksazolidinonforbindelser og sammensetninger og fremgangsmater relatert dertil
NO20071230L (no) Oksazolidinoner inneholdende oksindoler som antibakterielle midler
UA88448C2 (ru) Оксазолидиноновые антибиотики с замещенной циклопропильной группой и их производные
AR064326A1 (es) Un metodo para preparar derivados de taxano y compuestos intermedios utilizados en el mismo
WO2009116090A3 (fr) Nouveaux antimicrobiens
DOP2004000942A (es) Antibióticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos (cyclopropyl group substitued oxazoldinone antibiotics and derivatives thereof)
WO2006018682A3 (fr) Derives d'oxazolidinone comme antimicrobiens
NZ598129A (en) Process for the preparation of cathepsin s inhibitors
WO2009051096A1 (fr) Composé amide et procédé de contrôle des maladies des plantes l'utilisant
MY142362A (en) Pharmaceutical composition for promoting angiogenesis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application